Werfen to acquire Immucor for approximately $2 billion

Werfen announced it has agreed to acquire Immucor, Inc. from TPG for approximately US$2 billion. Immucor is a privately held diagnostics company headquartered in Norcross, Georgia. The transaction is expected to close during the first half of 2023.

“This acquisition will allow Werfen to expand its portfolio of Specialized Diagnostics solutions for hospitals and clinical laboratories.”newswire.ca

• 1 source
• newswire.caWerfen to Acquire Immucor, Inc., Expanding its Presence in Specialized DiagnosticsWerfenNov 3, 2022

Summarized from public sources; check the original articles before acting on it.